The TNF receptor-ligands 4-1BB-4-1BBL and GITR-GITRL in NK cell responses

被引：16
|
作者：
Barao, Isabel [1 ]
机构：
[1] Univ Nevada, Dept Microbiol & Immunol, Reno, NV 89557 USA
来源：
FRONTIERS IN IMMUNOLOGY | 2013年 / 3卷
关键词：
NK; leukemia; 4-1BB; GITR; therapy;
D O I：
10.3389/fimmu.2012.00402
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Interactions between several tumor necrosis factor (TNF)-TNF receptor (TNFR) superfamily members that are expressed by T cells and natural killer (NK) cells and various other cell types modulate immune responses. This review summarizes the current understanding of how the TNF ligand-TNFR interactions 4-1BBL with 4-1BB, and GITRL with glucocorticoid-induced TNFR-related (GITR) regulate NK cell mediated antitumor responses and discuss its therapeutic implications.
引用
收藏
页数：8
相关论文
共 50 条
  • [21] In Vivo Blockade of the PD-1 Receptor Suppresses HIV-1 Viral Loads and Improves CD4+ T Cell Levels in Humanized Mice
    Palmer, Brent E.
    Neff, C. Preston
    LeCureux, Jonathan
    Ehler, Angelica
    DSouza, Michelle
    Remling-Mulder, Leila
    Korman, Alan J.
    Fontenot, Andrew P.
    Akkina, Ramesh
    JOURNAL OF IMMUNOLOGY, 2013, 190 (01) : 211 - 219
  • [22] CD4-positive T-helper cell responses to the PASD1 protein in patients with diffuse large B-cell lymphoma
    Ait-Tahar, Kamel
    Liggins, Amanda P.
    Collins, Graham R.
    Campbell, Andrew
    Barnardo, Martin
    Cabes, Maite
    Lawrie, Charles H.
    Moir, Donald
    Hatton, Chris
    Banham, Alison H.
    Pulford, Karen
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (01): : 78 - 86
  • [23] Efficacy and Safety of CD28-or 4-1BB-Based CD19 CAR-T Cells in B Cell Acute Lymphoblastic Leukemia
    Zhao, Xiangyu
    Yang, Junfang
    Zhang, Xian
    Lu, Xin-An
    Xiong, Min
    Zhang, Jianping
    Zhou, Xiaosu
    Qi, Feifei
    He, Ting
    Ding, Yanping
    Hu, Xuelian
    De Smet, Floris
    Lu, Peihua
    Huang, Xiaojun
    MOLECULAR THERAPY-ONCOLYTICS, 2020, 18 : 272 - 281
  • [24] Impact of the Functional VNTR Variants of the Interleukin-1 Receptor Antagonist and Interleukin-4 Genes on Oral Squamous Cell Carcinoma
    Gumusay, Ozge
    Nursal, Ayse Feyda
    Yigit, Serbulent
    Tekcan, Akin
    Oz, Tuba
    ISTANBUL MEDICAL JOURNAL, 2019, 20 (03): : 202 - 207
  • [25] Peripheral CD4+ T cell signatures in predicting the responses to anti-PD-1/PD-L1 monotherapy for Chinese advanced non-small cell lung cancer
    Xia, Liliang
    Wang, Hui
    Sun, Mingjiao
    Yang, Yi
    Yao, Chengcheng
    He, Sheng
    Duan, Huangqi
    Xia, Weimin
    Sun, Ruiming
    Yao, Yaxian
    Chen, Zhiwei
    Zhao, Qiong
    Li, Hong
    Lu, Shun
    Wang, Ying
    SCIENCE CHINA-LIFE SCIENCES, 2021, 64 (10) : 1590 - 1601
  • [26] Immune Checkpoint Blockade via PD-L1 Potentiates More CD28-Based than 4-1BB-Based Anti-Carbonic Anhydrase IX Chimeric Antigen Receptor T Cells
    de Campos, Najla Santos Pacheco
    de Oliveira Beserra, Adriano
    Pereira, Pedro Henrique Barbosa
    Chaves, Alexandre Silva
    Fonseca, Fernando Luiz Affonso
    da Silva Medina, Tiago
    dos Santos, Tiago Goss
    Wang, Yufei
    Marasco, Wayne Anthony
    Suarez, Eloah Rabello
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (10)
  • [27] Domain analyses of the Runx1 transcription factor responsible for modulating T-cell receptor-β/CD4 and interleukin-4/interferon-γ expression in CD4+ peripheral T lymphocytes
    Uchino, Ryuji
    IMMUNOLOGY, 2009, 128 (01) : 16 - 24
  • [28] Anti-IL-23 receptor monoclonal antibody prevents CD4+ T cell-mediated colitis in association with decreased systemic Th1 and Th17 responses
    Imamura, Emiko
    Taguchi, Katsunari
    Sasaki-Iwaoka, Haruna
    Kubo, Satoshi
    Furukawa, Shigetada
    Morokata, Tatsuaki
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 824 : 163 - 169
  • [29] Activated mouse CD4+Foxp3- T cells facilitate melanoma metastasis via Qa-1-dependent suppression of NK-cell cytotoxicity
    Wang, Xiaojuan
    Cui, Yanyan
    Luo, Gaoxing
    Wang, Qinghong
    Hu, Jie
    He, Weifeng
    Yuan, Jun
    Zhou, Junyi
    Wu, Yan
    Sun, Xiaofeng
    Robson, Simon C.
    Li, Xianchang
    Tan, Jiangling
    Peng, Yanmeng
    Xue, Gang
    Lu, Linrong
    Gao, Wenda
    Wu, Jun
    CELL RESEARCH, 2012, 22 (12) : 1696 - 1706
  • [30] 4-1BB Signaling Boosts the Anti-Tumor Activity of CD28-Incorporated 2nd Generation Chimeric Antigen Receptor-Modified T Cells
    Dai, Qiang
    Han, Ping
    Qi, Xinyue
    Li, Fanlin
    Li, Min
    Fan, Lilv
    Zhang, Huihui
    Zhang, Xiaoqing
    Yang, Xuanming
    FRONTIERS IN IMMUNOLOGY, 2020, 11
12345